Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges

Biomaterials

Volumn 74, Issue , 2016, Pages 155-166

  Li, Kuei Chang ^a   Chang, Yu Han ^b   Yeh, Chia Lin ^a   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

BMP2; Bone defect; microRNA; miR 214; miRNA sponge; Osteoporosis

Indexed keywords

CELL CULTURE; DEFECT DENSITY; DEFECTS; DISEASES; FLOWCHARTING; MOLECULAR BIOLOGY; RNA;

BMP2; BONE DEFECT; MICRORNAS; MIR-214; MIRNA SPONGE; OSTEOPOROSIS;

BONE;

BACULOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; MICRORNA; MICRORNA 140; MICRORNA 214; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACULOVIRIDAE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); FEMALE; FEMUR METAPHYSIS; FRACTURE HEALING; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRABECULAR BONE; ANIMAL; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; OVARIECTOMY; PATHOLOGY;

ANIMALS; BACULOVIRIDAE; BONE MARROW CELLS; FRACTURE HEALING; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOPOROSIS; OVARIECTOMY; RATS; X-RAY MICROTOMOGRAPHY;

EID: 84945151207     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.09.046     Document Type: Article

References (58)

1. Muruganandan S., Dranse H.J., Rourke J.L., McMullen N.M., Sinal C.J. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells 2013, 31:2172-2182.
2. Seeliger C., Karpinski K., Haug A.T., Vester H., Schmitt A., Bauer J.S., et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J. Bone Min. Res. 2014, 29:1718-1728.
3. Kim K.M., Lim S.K. Role of miRNAs in bone and their potential as therapeutic targets. Curr. Opin. Pharmacol. 2014, 16:133-141.
4. Deal C. Potential new drug targets for osteoporosis. Nat. Clin. Pract. Rheumatol. 2009, 5:20-27.
5. Li K.-C., Hu Y.-C. Cartilage tissue engineering: recent advances and perspectives from gene regulation/therapy. Adv. Healthc. Mater. 2015, 4:948-968.
6. Lian J.B., Stein G.S., van Wijnen A.J., Stein J.L., Hassan M.Q., Gaur T., et al. MicroRNA control of bone formation and homeostasis. Nat. Rev. Endocrinol. 2012, 8:212-227.
7. van Wijnen A.J., van de Peppel J., van Leeuwen J.P., Lian J.B., Stein G.S., Westendorf J.J., et al. MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr. Osteoporos. Rep. 2013, 11:72-82.
8. Clark E.A., Kalomoiris S., Nolta J.A., Fierro F.A. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells 2014, 32:1074-1082.
9. Sugatani T., Hruska K.A. Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. J. Cell Biochem. 2013, 114:1217-1222.
10. Airenne K.J., Hu Y.-C., Kost T.A., Smith R.H., Kotin R.M., Ono C., et al. Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol. Ther. 2013, 21:739-749.
11. Sung L.-Y., Chen C.-L., Lin S.-Y., Li K.-C., Yeh C.-L., Chen G.-Y., et al. Efficient gene delivery into cell lines and stem cells using baculovirus. Nat. Protoc. 2014, 9:1882-1899.
12. Lin C.-Y., Chang Y.-H., Kao C.-Y., Lu C.-H., Sung L.-Y., Yen T.-C., et al. Augmented healing of critical-size calvarial defects by baculovirus-engineered MSCs that persistently express growth factors. Biomaterials 2012, 33:3682-3692.
13. Lin C.-Y., Chang Y.-H., Li K.-C., Lu C.-H., Sung L.-Y., Yeh C.-L., et al. The use of ASCs engineered to express BMP2 or TGF-β3 within scaffold constructs to promote calvarial bone repair. Biomaterials 2013, 34:9401-9412.
14. Lin C.-Y., Chang Y.-H., Lin K.-J., Yen T.-Z., Tai C.-L., Chen C.-Y., et al. The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 2010, 31:3222-3230.
15. Lin C.-Y., Chang Y.-H., Sung L.-Y., Lu C.-H., Chen C.-L., Lin S.-Y., et al. Long-term follow-up of massive segmental bone healing mediated by hybrid baculovirus-transduced ASCs: Focuses on bone remodeling and potential side effects. Tissue Eng. Part A 2014, 20:1392-1402.
16. Lin C.-Y., Lin K.-J., Kao C.-Y., Chen M.-C., Yen T.-Z., Lo W.-H., et al. The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials 2011, 32:6505-6514.
17. Lin C.-Y., Lin K.-J., Li K.-C., Sung L.-Y., Hsueh S., Lu C.-H., et al. Immune responses during healing of massive segmental femoral bone defects mediated by hybrid baculovirus-engineered ASCs. Biomaterials 2012, 33:7422-7434.
18. Lin C.-Y., Wang Y.-H., Li K.-C., Sung L.-Y., Yeh C.-L., Lin K.-J., et al. Healing of massive segmental femoral bone defects in minipigs by allogenic ASCs engineered with FLPo/Frt-based baculovirus vectors. Biomaterials 2015, 50:98-106.
19. Liao Y.-H., Chang Y.-H., Sung L.-Y., Li K.-C., Yeh C.-L., Yen T.-C., et al. Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b. Biomaterials 2014, 35:4901-4910.
20. Ho Y.-C., Chung Y.-C., Hwang S.-M., Wang K.-C., Hu Y.-C. Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J. Gene Med. 2005, 7:860-868.
21. Chen C.-Y., Wu H.-H., Chen C.-P., Chern S.-R., Hwang S.-M., Huang S.-F., et al. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol. Pharm. 2011, 8:1505-1514.
22. Sung L.Y., Chen C.L., Lin S.Y., Hwang S.M., Lu C.H., Li K.C., et al. Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. Nucleic Acids Res. 2013, 41:e139.
23. Bellido M., Lugo L., Roman-Blas J.A., Castaneda S., Caeiro J.R., Dapia S., et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res. Ther. 2010, 12:R152.
24. Lin C.Y., Chang Y.H., Li K.C., Lu C.H., Sung L.Y., Yeh C.L., et al. The use of ASCs engineered to express BMP2 or TGF-beta3 within scaffold constructs to promote calvarial bone repair. Biomaterials 2013, 34:9401-9412.
25. Wang X., Guo B., Li Q., Peng J., Yang Z., Wang A., et al. miR-214 targets ATF4 to inhibit bone formation. Nat. Med. 2013, 19:93-100.
26. Cao L., Liu G., Gan Y., Fan Q., Yang F., Zhang X., et al. The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Biomaterials 2012, 33:5076-5084.
27. Osako M.K., Nakagami H., Koibuchi N., Shimizu H., Nakagami F., Koriyama H., et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ. Res. 2010, 107:466-475.
28. Yao W., Cheng Z., Shahnazari M., Dai W., Johnson M.L., Lane N.E. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J. Bone Min. Res. 2010, 25:190-199.
29. Takahashi N., Udagawa N., Kobayashi Y., Suda T. Generation of osteoclasts in vitro, and assay of osteoclast activity. Methods Mol. Med. 2007, 135:285-301.
30. Staines K.A., MacRae V.E., Farquharson C. The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling. J. Endocrinol. 2012, 214:241-255.
31. Li H., Xie H., Liu W., Hu R., Huang B., Tan Y.F., et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest. 2009, 119:3666-3677.
32. Wang Y., Li L., Moore B.T., Peng X.-H., Fang X., Lappe J.M., et al. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS ONE 2012, 7:e34641.
33. Hwang S., Park S.K., Lee H.Y., Kim S.W., Lee J.S., Choi E.K., et al. miR-140-5p suppresses BMP2-mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett. 2014, 588:2957-2963.
34. Yang J., Qin S.Y., Yi C.Q., Ma G., Zhu H., Zhou W.R., et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett. 2011, 585:2992-2997.
35. Buechli M.E., Lamarre J., Koch T.G. MicroRNA-140 expression during chondrogenic differentiation of equine cord blood-derived mesenchymal stromal cells. Stem Cells Dev. 2013, 22:1288-1296.
36. Nakamura Y., Inloes J.B., Katagiri T., Kobayashi T. Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol. Cell Biol. 2011, 31:3019-3028.
37. Karlsen T.A., Jakobsen R.B., Mikkelsen T.S., Brinchmann J.E. microRNA-140 targets RALA and regulates chondrogenic differentiation of human mesenchymal stem cells by translational enhancement of SOX9 and ACAN. Stem Cells Dev. 2014, 23:290-304.
38. Hill C.R., Yuasa M., Schoenecker J., Goudy S.L. Jagged1 is essential for osteoblast development during maxillary ossification. Bone 2014, 62:10-21.
39. Tanaka K., Inoue Y., Hendy G.N., Canaff L., Katagiri T., Kitazawa R., et al. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone 2012, 51:158-167.
40. Oliver R.A., Yu Y., Yee G., Low A.K., Diwan A.D., Walsh W.R. Poor histological healing of a femoral fracture following 12 months of oestrogen deficiency in rats. Osteoporos. Int. 2013, 24:2581-2589.
41. Chen H., Shalom-Feuerstein R., Riley J., Zhang S.D., Tucci P., Agostini M., et al. miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro. Biochem. Biophys. Res. Commun. 2010, 394:921-927.
42. Sehic A., Risnes S., Khuu C., Khan Q.E., Osmundsen H. Effects of in vivo transfection with anti-miR-214 on gene expression in murine molar tooth germ. Physiol. Genomics 2011, 43:488-498.
43. Joglekar M.V., Parekh V.S., Hardikar A.A. New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol. Metab. 2007, 18:393-400.
44. Ahmed M.I., Alam M., Emelianov V.U., Poterlowicz K., Patel A., Sharov A.A., et al. MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway. J. Cell Biol. 2014, 207:549-567.
45. van Mil A., Grundmann S., Goumans M.J., Lei Z., Oerlemans M.I., Jaksani S., et al. MicroRNA-214 inhibits angiogenesis by targeting quaking and reducing angiogenic growth factor release. Cardiovasc. Res. 2012, 93:655-665.
46. 2+ overload and cell death. J. Clin. Invest. 2012, 122:1222-1232.
47. Watanabe T., Sato T., Amano T., Kawamura Y., Kawamura N., Kawaguchi H., et al. Dnm3os, a non-coding RNA, is required for normal growth and skeletal development in mice. Dev. Dyn. 2008, 237:3738-3748.
48. Shi K., Lu J., Zhao Y., Wang L., Li J., Qi B., et al. MicroRNA-214 suppresses osteogenic differentiation of C2C12 myoblast cells by targeting Osterix. Bone 2013, 55:487-494.
49. Chen Y., Whetstone H.C., Youn A., Nadesan P., Chow E.C., Lin A.C., et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J. Biol. Chem. 2007, 282:526-533.
50. Ono M., Inkson C.A., Kilts T.M., Young M.F. WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J. Bone Min. Res. 2011, 26:193-208.
51. Salingcarnboriboon R.A., Pavasant P., Noda M. Cbl-b enhances Runx2 protein stability and augments osteocalcin promoter activity in osteoblastic cell lines. J. Cell Physiol. 2010, 224:743-747.
52. Zhao C., Sun W., Zhang P., Ling S., Li Y., Zhao D., et al. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 2015, 12:343-353.
53. Xia H., Ooi L.L., Hui K.M. MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One 2012, 7:e44206.
54. Mbalaviele G., Sheikh S., Stains J.P., Salazar V.S., Cheng S.L., Chen D., et al. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell Biochem. 2005, 94:403-418.
55. van Balkom B.W.M., de Jong O.G., Smits M., Brummelman J., den Ouden K., de Bree P.M., et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 2013, 121:3997-4006.
56. Yang H., Kong W., He L., Zhao J.J., O'Donnell J.D., Wang J., et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008, 68:425-433.
57. Xu C.X., Xu M., Tan L., Yang H., Permuth-Wey J., Kruk P.A., et al. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J. Biol. Chem. 2012, 287:34970-34978.
58. Xu Z., Wang T. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1. Biochem. Biophys. Res. Commun. 2014, 449:190-195.